SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 149 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $23,383,625 | -9.3% | 1,011,369 | +2.8% | 0.01% | 0.0% |
Q2 2023 | $25,781,481 | +25.9% | 983,353 | +23.6% | 0.01% | +14.3% |
Q1 2023 | $20,474,665 | +288438.1% | 795,463 | +191.5% | 0.01% | +250.0% |
Q4 2022 | $7,096 | -99.7% | 272,892 | +197.1% | 0.00% | +100.0% |
Q3 2022 | $2,617,000 | -30.5% | 91,842 | -40.0% | 0.00% | 0.0% |
Q2 2022 | $3,768,000 | -65.9% | 153,000 | -21.8% | 0.00% | -66.7% |
Q1 2022 | $11,040,000 | -7.4% | 195,539 | +1.7% | 0.00% | -25.0% |
Q4 2021 | $11,916,000 | -4.1% | 192,243 | -1.8% | 0.00% | 0.0% |
Q3 2021 | $12,423,000 | +99.8% | 195,836 | +159.3% | 0.00% | +100.0% |
Q2 2021 | $6,219,000 | – | 75,513 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 5,831,307 | $480,558,000 | 31.49% |
Consonance Capital Management LP | 1,199,339 | $98,838,000 | 11.90% |
Boxer Capital, LLC | 2,075,905 | $171,075,000 | 6.04% |
Perceptive Advisors | 9,699,824 | $799,362,000 | 5.19% |
Orbimed Advisors | 6,044,266 | $498,108,000 | 5.04% |
Samsara BioCapital, LLC | 169,852 | $13,998,000 | 1.73% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 1,375,775 | $113,378,000 | 1.50% |
SPHERA FUNDS MANAGEMENT LTD. | 195,117 | $16,080,000 | 1.09% |
Artal Group S.A. | 500,000 | $41,205,000 | 0.84% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $46,032,000 | 0.82% |